Mosquitocidal efficacy and pharmacokinetics of single-dose ivermectin versus three-day dose regimen for malaria vector control compared with albendazole and no treatment: An open-label randomized controlled trial

This publication has 25 references indexed in Scilit:

• Mass drug administration of ivermectin and dihydroartemisinin–piperaquine against malaria in settings with high coverage of standard control interventions: a cluster-randomised controlled trial in The Gambia
  The Lancet Infectious Diseases, 2022
• Identification of the metabolites of ivermectin in humans
  Pharmacology Research & Perspectives, 2021
• Ivermectin as a novel complementary malaria control tool to reduce incidence and prevalence: a modelling study
  The Lancet Infectious Diseases, 2020
• Safety, Pharmacokinetics, and Mosquito‐Lethal Effects of Ivermectin in Combination With Dihydroartemisinin‐Piperaquine and Primaquine in Healthy Adult Thai Subjects
  Clinical Pharmacology & Therapeutics, 2019
• Development and validation of an LC-MS/MS method for the analysis of ivermectin in plasma, whole blood, and dried blood spots using a fully automatic extraction system
  Journal of Pharmaceutical and Biomedical Analysis, 2019
• Population pharmacokinetics of oral ivermectin in venous plasma and dried blood spots in healthy volunteers
  British Journal of Clinical Pharmacology, 2018
• Pharmacokinetics‐Pharmacodynamics of High‐Dose Ivermectin with Dihydroartemisinin‐Piperaquine on Mosquitocidal Activity and QT‐Prolongation (IVERMAL)
  Clinical Pharmacology & Therapeutics, 2018
• Safety and mosquitocidal efficacy of high-dose ivermectin when co-administered with dihydroartemisinin-piperaquine in Kenyan adults with uncomplicated malaria (IVERMAL): a randomised, double-blind, placebo-controlled trial
  The Lancet Infectious Diseases, 2018
• The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015
  Nature, 2015
• Efficacy and Safety of the Mosquitocidal Drug Ivermectin to Prevent Malaria Transmission After Treatment: A Double-Blind, Randomized, Clinical Trial
  Clinical Infectious Diseases, 2014